Monthly Archives - November 2021

Immusoft Receives $4M in Funding from the California Institute for Regenerative Medicine (CIRM)

Immusoft of CA, a wholly owned subsidiary of Immusoft Corporation, a cell therapy company dedicated to improving the lives of patients with rare diseases, announced today that the California Institute for Regenerative Medicine (CIRM) has awarded the company a $4M grant to support the development of its ISP-002 (for delivery of iduronate sulfatase) program in mucopolysaccharidosis type II (MPS II), an inherited disease for which patients have limited options. MPS II is a rare genetic disease in children, which […]

Regroup Mass Notification Honored with 2021 ‘ASTORS’ Homeland Security Award for Best Mass Notification System

Regroup Mass Notification ( today announced it is the recipient of a 2021 ‘ASTORS’ Homeland Security Award from American Security Today for its mass notification solution. American Security Today’s Annual ‘ASTORS’ Awards is the preeminent U.S. Homeland Security Awards Program, and today in its Sixth Year, continues to recognize industry leaders of Physical and Border Security, Cybersecurity, Emergency Preparedness – Management and Response, Law Enforcement, First Responders, as well as federal, state and municipal government agencies in the acknowledgment […]

Parents – Do you Or Your Child Qualify for Public Service Loan Forgiveness?

The Biden Administration’s temporary rule changes to the PSLF program are poised to impact hundreds of thousands of borrowers. “Since PSLF launched in 2007, only 16,000 participants have received forgiveness—but that’s not for borrowers’ lack of trying. Only 2.1 percent of applicants have been approved in the program’s lifetime, which critics say is the result of rampant mismanagement, unfair review practices, and an inadequate program design from the start,” says Laurel Taylor, CEO,, a platform designed to address […]

Stem Cell Agency Board Invests in Therapy Targeting Deadly Blood Cancers

Hematologic malignancies are cancers that affect the blood, bone marrow and lymph nodes and include different forms of leukemia and lymphoma. Current treatments can be effective, but in those patients that do not respond, there are few treatment options. Today, the governing Board of the California Institute for Regenerative Medicine (CIRM) approved investing $4.1 million in a therapy aimed at helping patients who have failed standard therapy. The CIRM Board also approved investing $44,101,935 in 11 projects as part […]

Wasabi Technologies Launches London Storage Region as it Ramps Up Global Expansion Plans

Wasabi Technologies, the hot cloud storage company, today announced the opening of a new storage region in London that will expand the availability and speed of services throughout the UK. Building on strong momentum for Wasabi in Europe following a major distribution partnership with Exclusive Networks, one of Europe’s largest cybersecurity distributors, the London site also accelerates the company’s rapid global expansion with plans to open additional storage regions in the next year. Read more >>

Astrocyte Pharmaceuticals Announces Publication in the Journal Stroke of Results Supporting Advancement of AST-004 into in the Clinic

Astrocyte Pharmaceuticals Inc., a drug discovery and development company advancing novel neuroprotective therapeutics for the treatment of brain injuries, today announced the publication of a manuscript in the peer reviewed journal Stroke entitled: Adenosine A1R/A3R (Adenosine A1 and A3 Receptor) Agonist AST-004 Reduces Brain Infarction in a Nonhuman Primate Model of Stroke. The manuscript describes the results of pre-clinical studies using AST-004, Astrocyte’s lead drug candidate, for the treatment of stroke. Read more >>